About

MELISSA aims to innovate diabetes treatment and care for people with insulin-treated diabetes through the development of a clinically validated, efficient and cost-effective Artificial Intelligence-based digital diabetes management solution. This will contribute to every person with insulin-treated diabetes receiving tailored treatment and care according to their individual needs, habits and evolution resulting in a better quality of life. Health care providers will be able to better predict patients’ responses to the individually tailored treatment. They can also rely on improved clinical guidelines thanks to the novel, clinically validated and (cost-) effective AI solutions. As such, MELISSA will be the first AI-powered solution to go through regulatory approval for clinical investigation in several European countries.